Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Bloch SB, Larsen M (2015) Translational public health care perspective: intravitreal treatment of neovascular age-related macular degeneration has revolutionized clinical ophthalmology. Acta Ophthalmol 93:103–104. https://doi.org/10.1111/aos.12680
2. Lee AY, Day AC, Egan C, Bailey C, Johnston RL, Tsaloumas MD, Denniston AK, Tufail A (2016) Previous intravitreal therapy is associated with increased risk of posterior capsule rupture during cataract surgery. Ophthalmology 123(6):1252–1256. https://doi.org/10.1016/j.ophtha.2016.02.014
3. Williams GA. IVT Injections (2014) Health policy implications. Review of ophthalmology. Review of Ophthalmology. https://www.reviewofophthalmology.com/article/ivt-injections-health-policy-implications . Accessed 27 June 2023
4. Mahajan VB, Elkins KA, Russell SR, Boldt HC, Gehrs KM, Weingeist TA, Stone EM, Abràmoff MD, Liu D, Folk JC (2011) Bilateral intravitreal injection of antivascular endothelial growth factor therapy. Retina 31(1):31–35. https://doi.org/10.1097/IAE.0b013e3181ed8c80
5. Freund KB, Vance SK (2011) Systemic safety of bilateral intravitreal anti-vascular endothelial growth factor injections. Retina 31(1):1–3. https://doi.org/10.1097/IAE.0b013e318203c0ef